Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;95(1):e28306.
doi: 10.1002/jmv.28306.

Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies

Affiliations
Review

Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies

Ali A Rabaan et al. J Med Virol. 2023 Jan.

Abstract

Monkeypox is a rare zoonotic disease caused by infection with the monkeypox virus. The disease can result in flu-like symptoms, fever, and a persistent rash. The disease is currently spreading throughout the world and prevention and treatment efforts are being intensified. Although there is no treatment that has been specifically approved for monkeypox virus infection, infected patients may benefit from using certain antiviral medications that are typically prescribed for the treatment of smallpox. The drugs are tecovirimat, brincidofovir, and cidofovir, all of which are currently in short supply due to the spread of the monkeypox virus. Resistance is also a concern, as widespread replication of the monkeypox virus can lead to mutations that produce monkeypox viruses that are resistant to the currently available treatments. This article discusses monkeypox disease, potential drug targets, and management strategies to overcome monkeypox disease. With the discovery of new drugs, it is hoped that the problem of insufficient drugs will be resolved, and it is not anticipated that drug resistance will become a major issue in the near future.

Keywords: Monkeypox; disease management; drug target; orthopoxvirus.

PubMed Disclaimer

References

REFERENCES

    1. Alakunle EF, Okeke MI. Monkeypox virus: a neglected zoonotic pathogen spreads globally. Nat Rev Microbiol. 2022;20(9):507-508. doi:10.1038/s41579-022-00776-z
    1. Mahmoud A, Nchasi G. Monkeypox virus: a zoonosis of concern. J Med Virol. 2022:1-2. doi:10.1002/jmv.27968
    1. Sklenovská N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health. 2018;6:241. doi:10.3389/fpubh.2018.00241
    1. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Neglected Trop Dis. 2022;16(2):e0010141. doi:10.1371/journal.pntd.0010141
    1. Wise J. Monkeypox: new clinical symptoms are identified in confirmed cases. BMJ. 2022;378:o1845. doi:10.1136/bmj.o1845

MeSH terms

LinkOut - more resources